$NVAX

Uncategorized

Is It Worth Waiting For Novavax’s (NASDAQ: NVAX) Vaccine Candidate?

user - February 13, 2021

Novavax Inc. (NASDAQ: NVAX) is preparing to get authorization for its coronavirus vaccine. The firm is currently near the finish line and will soon...

Uncategorized

Novavax (NASDAQ: NVAX) Strikes 51M COVID Vaccine Doses Deal With Australia

user - January 8, 2021

Novavax, Inc. (NASDAQ: NVAX) has completed the COVID-19 vaccine supply deal with the Commonwealth of Australia. As per the deal, Novavax is scheduled to...

Uncategorized

Novavax (NASDAQ: NVAX) Announces Delay In Coronavirus Trial

user - November 30, 2020

Novavax, Inc. (NASDAQ: NVAX) has provided updates regarding its late-stage coronavirus study. The company has disclosed that it is planning to commence Phase III...